However, it has been shown that NRF2 is activated in a cell model of huntingtin overexpression, inferring that NRF2 is responsible for mitigating some of the harmful effects brought on by HD progression (van Roon-Mom et al., 2008). The gene discussed is NFE2L2; the disease is Huntington disease.